Protocol 802-247-09-015: A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study investigating the Efficacy of HP802-247 in Venous Leg Ulcers

Project: Research project

Project Details

StatusFinished
Effective start/end date7/15/107/15/13

Funding

  • Healthpoint, Ltd. (802-247-09-015)